SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Vitae Pharmaceuticals, Inc. Receives $14 Million Milestone Payment as Boehringer Ingelheim Corporation Advances Lead Compound into Phase I Clinical Trials